Reduced activity of the PI3K/Akt signaling pathway has been observed to result in pathological changes, including reduced neuronal viability, impaired synaptic plasticity, and metabolic abnormalities in AD [181]. This evidence concerns the gene AKT1 and Alzheimer disease.